Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov 26;43(11):114969.
doi: 10.1016/j.celrep.2024.114969. Epub 2024 Nov 14.

Histone H1 kills MRSA

Affiliations
Free article

Histone H1 kills MRSA

Gerben Marsman et al. Cell Rep. .
Free article

Abstract

The antimicrobial activity of histones was discovered in the 1940s, but their mechanism of action is not fully known. Here we show that methicillin-resistant Staphylococcus aureus (MRSA) is susceptible to histone H1 (H1), even in the presence of divalent cations and serum. Through selective evolution and a genome-wide screen of a transposon library, as well as physiological and pharmacological experiments, we elucidated how H1 kills MRSA. We show that H1 first binds to wall teichoic acids with high affinity. Once bound, H1 requires a potentiated membrane and a metabolically active bacterium to permeabilize the membrane and enter the cell. Upon entry, H1 accumulates intracellularly, in close association with the bacterial DNA. Of note, anti-H1 antibodies inhibit neutrophil extracellular trap killing of MRSA. Moreover, H1 colocalizes with bacterial DNA in abscess samples of MRSA-infected patients, suggesting a role for H1 in combating MRSA in vivo.

Keywords: CP: Microbiology; MRSA; Staphylococcus aureus; antimicrobial peptides; antimicrobial resistance; histones; neutrophil extracellular traps; wall teichoic acids.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests V.J.T. is an inventor on patents and patent applications filed by New York University, which are currently under the commercial license to Janssen Biotech Inc. (JBIO). JBIO provides research funding and other payments associated with an exclusive licensing agreement to V.J.T. The work presented herein is unrelated to these patents.

References

Publication types

MeSH terms

LinkOut - more resources